This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Chewy (CHWY) Tumbles 14% on Wider-Than-Expected Q4 Loss
by Zacks Equity Research
Chewy's (CHWY) fourth-quarter fiscal 2021 results reflect supply-chain disruptions and higher inbound freight expenses.
Flowers Foods' (FLO) Prudent Acquisitions & Pricing Aid Sales
by Zacks Equity Research
Flowers Foods (FLO) is focusing on acquisitions to strengthen its product portfolio and expand in untapped markets. The company is benefiting from its pricing efforts for a while now.
Newell's (NWL) NUK Launches Sustainable Baby Collection
by Zacks Equity Research
Newell's (NWL) NUK brand launches its first sustainable babywear products made of recycled fiber. The product line includes seven products available in stores and online at Target.
Are Investors Undervaluing Nomad Foods Limited (NOMD) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nomad Foods (NOMD) Could Find Support Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Nomad Foods (NOMD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Nomad Foods (NOMD) Q4 Earnings Match Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 0% and 1.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Nomad Foods (NOMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Nomad Foods (NOMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Nomad Foods Limited (NOMD) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Clorox (CLX) Lags Q2 Earnings Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of -15.38% and 0.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Pick Nomad Foods (NOMD) Stock Now?
by Vedika Agarwal
Is Nomad Foods (NOMD) a great pick from the value investor's perspective right now? Read on to know more.
Nomad Foods (NOMD) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 17.14% and 2.75%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Nomad Foods (NOMD) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Nomad Foods (NOMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 18th
by Zacks Equity Research
CYTK, GEVO, ISEE, MCFE, and NOMD have been added to the Zacks Rank #5 (Strong Sell) List on August 18, 2021.
Nomad Foods (NOMD) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 26.32% and 3.02%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Nomad Foods (NOMD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nomad Foods (NOMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Service Corporation (SCI) Seems to be in a Good Spot: Here's Why
by Zacks Equity Research
Service Corporation (SCI) has been benefiting from greater operations amid the pandemic, which led to increased mortality. Also, solid cost control has been a driver.
Philip Morris (PM) to Boost Smoke-Free Options With Fertin Pharma
by Zacks Equity Research
Philip Morris (PM) is expected to complete the acquisition of Fertin Pharma by fourth-quarter fiscal 2021. The move is likely to help its innovation capabilities in the oral delivery platform.
McCormick's (MKC) Q2 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
McCormick's (MKC) second-quarter fiscal 2021 results reflect the impact of higher sales driven by growth in the Flavor Solutions unit. Management raises fiscal 2021 view.
Get Over the Meme Frenzy, Dig Into These 4 Food Stocks Instead
by Vrishali Bagree
Food stocks like Darling Ingredients (DAR), Medifast (MED), Hain Celestial (HAIN) and Nomad Foods (NOMD) are great investment options for those looking to bypass the meme craze.
General Mills' (GIS) Q4 Earnings & Sales Top Estimates, Drop Y/Y
by Vrishali Bagree
General Mills' (GIS) fourth-quarter fiscal 2021 results reflect lower earnings and sales due to tough comparisons with the year-ago period's demand surge.
Purple Innovation (PRPL) Lowers Q2 & Withdraws 2021 Outlook
by Zacks Equity Research
Purple Innovation (PRPL) trims second-quarter 2021 outlook due to production threats triggered by unexpected mechanical and maintenance snags.
Conagra (CAG) Unveils Product Innovations to Drive Growth
by Zacks Equity Research
Conagra (CAG) unveils an impressive line-up of product innovations including meals and sides inspired from great flavor and quality, including plant-based offerings.
Archer Daniels (ADM) Gains on Strategic Moves & Nutrition Unit
by Zacks Equity Research
Archer Daniels (ADM) smoothly advances on its growth pillars that assure to optimize the core, drive efficiencies and expand strategically.
Pilgrim's Pride (PPC) Benefits on Capacity & Portfolio Growth
by Zacks Equity Research
Pilgrim's Pride (PPC) prudent operational strategies, including buyouts and capacity expansion for key products, are driving performance across key markets.
Conagra's (CAG) Faster Cage-Free Egg Transition to Cheer Consumers
by Zacks Equity Research
Conagra (CAG) now targets using 100% cage-free eggs by fiscal 2024-end compared with the earlier plan of fiscal 2025. This goes in line with consumers' focus on animal welfare.